
Join to View Full Profile
1120 W Michigan StIndianapolis, IN 46202
Phone+1 317-278-2694
Fax+1 317-278-2650
Dr. Adra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2014 - 2017
- American University of Beirut Faculty of MedicineClass of 2010
- Indiana University School of MedicineResidency, Internal Medicine
Certifications & Licensure
- IN State Medical License 2017 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Accuracy of 18F-FDG PET in Early Metastatic Testicular Seminoma: Analysis from the SEMS Trial.Brian Hu, Muhannad Alsyouf, Ala'a Farkouh, Clint Cary, Timothy Masterson
The Journal of Urology. 2025-04-09 - A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC.Andrew W Hahn, Nabil Adra, Ulka Vaishampayan, Lianchun Xiao, Nazli Dizman
The Oncologist. 2025-04-04 - A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advance...Roberto Pili, David I Quinn, Nabil Adra, Theodore Logan, Sean Colligan
Cancer Medicine. 2025-04-01
Press Mentions
- The Importance of Having Mentors, Both Locally and GloballyMarch 11th, 2020
- SWOG Reports Results in Gynecologic Cancer Immunotherapy TrialJanuary 20th, 1970
- SUO 2020: Clinical Application for Novel Biomarkers in Testis CancerDecember 6th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: